AXERT is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Almotriptan Malate.
| Product ID | 50458-211_33016f86-638b-11ea-802d-5119fc2ca371 |
| NDC | 50458-211 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AXERT |
| Generic Name | Almotriptan Malate |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2001-05-07 |
| Marketing End Date | 2024-07-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021001 |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | ALMOTRIPTAN MALATE |
| Active Ingredient Strength | 6 mg/1 |
| Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2001-05-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021001 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2001-05-07 |
| Marketing End Date | 2019-07-31 |
| Ingredient | Strength |
|---|---|
| ALMOTRIPTAN MALATE | 6.25 mg/1 |
| SPL SET ID: | a8479ec0-204e-11e1-aa3f-a3c74724019b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-210 | AXERT | almotriptan malate |
| 50458-211 | AXERT | almotriptan malate |
| 0093-5260 | Almotriptan Malate | Almotriptan Malate |
| 0093-5261 | Almotriptan Malate | Almotriptan Malate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AXERT 75832455 2534682 Live/Registered |
ALMIRALL, S.A. 1999-10-26 |